Reported Mar 27, 2024 · Terminated

Digoxin Tablets, USP 125mcg, (0.125 mg), 1000-count bottle, Rx Only, Manufactured by: Novitium Pharma LLC., 70 Lake…

Novitium Pharma LLC

Low riskThis product is unlikely to cause harm, but it breaks a safety or labelling rule.

What you should do

Stop using the affected lot and contact the recalling firm for the return or refund process. Check the FDA enforcement report for lot-level detail.

Firm contact: Novitium Pharma LLC · 70 Lake Dr · East Windsor, NJ · 08520-5321

Is this the product you have?

    • Digoxin Tablets
    • USP 125mcg
    • (0.125 mg)
    • 1000-count bottle
    • Rx Only
  • Manufactured by
    • Novitium Pharma LLC
    • 70 Lake Drive
    • East Windsor
    • New Jersey 08520
    • NDC 70954-201-20
Lot codes and dates
    • Lot #: M23172A
    • Exp 01/31/2025
Amount recalled
3,940 1000-count bottles

Where it was sold

  • Nationwide

Why it was recalled

Cross Contamination with Other Products:(mycophenolate mofetil).

This product is unlikely to cause harm, but it breaks a safety or labelling rule.

Want the full recall guide?

The guide adds the identifying codes laid out for scanning, symptoms to watch for, a timeline, and news coverage of this recall.

Free recall alerts

Get alerted about new Novitium Pharma LLC recalls

One email when a matching recall is published. No account, no cost, unsubscribe in one click.

Where this came from

Source: U.S. Food & Drug Administration (openFDA)

Read the FDA (openFDA drug enforcement) notice

Notice updated Mar 21, 2025 · Data as of Sep 19, 8:07 PM UTC

RecallNow is not a government agency. Every fact on this page is published by the FDA, USDA or CPSC and links back to their notice.